Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Provention Bio
Provention Bio
(PRVB)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tzield
Teplizumab
2022-11-17
Type 1 diabetes mellitus
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Teplizumab
diabetes mellitus
,
type 1 diabetes mellitus
Cilmostim
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
small cell lung carcinoma
,
lymphoma
,
hiv infections
,
large b-cell lymphoma diffuse
,
cytomegalovirus retinitis
,
retinitis
,
b-cell lymphoma
,
non-hodgkin lymphoma
,
infections
EDICOTINIB
crohn disease
Globulin, immune
healthy volunteers/patients
,
large b-cell lymphoma diffuse
,
chronic pain
,
hodgkin disease
,
squamous cell neoplasms
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
hematologic neoplasms
,
alzheimer disease
,
pain
,
osteoarthritis
,
urologic neoplasms
,
transitional cell carcinoma
,
sarcoma
,
adenocarcinoma
,
colorectal neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
stomach neoplasms
,
recurrence
,
small cell lung carcinoma
,
squamous cell carcinoma
,
pancreatic ductal carcinoma
,
fallopian tube neoplasms
,
b-cell lymphoma
,
non-hodgkin lymphoma
,
renal cell carcinoma
,
uterine cervical neoplasms
,
prostatic neoplasms
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
esophageal neoplasms
,
waldenstrom macroglobulinemia
,
small cell carcinoma
,
neoplasm metastasis
,
ovarian epithelial carcinoma
,
uterine neoplasms
,
cholangiocarcinoma
,
leiomyosarcoma
,
serous cystadenocarcinoma
,
hereditary breast and ovarian cancer syndrome
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
ulcerative colitis
,
colitis
,
ulcer
,
lymphoproliferative disorders
,
b-cell lymphoma marginal zone
,
mantle-cell lymphoma
,
castration-resistant prostatic neoplasms
,
female genital neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
epstein-barr virus infections
,
oropharyngeal neoplasms
,
glioblastoma
,
glioma
,
peripheral nervous system diseases
,
rare diseases
,
adenocarcinoma of lung
,
brain neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
neoplasms
,
carcinoma
,
triple negative breast neoplasms
,
squamous cell carcinoma of head and neck
,
urinary bladder neoplasms
,
biliary tract neoplasms
,
lymphoma
,
endometrial neoplasms
,
melanoma
,
head and neck neoplasms
,
respiratory syncytial virus infections
,
covid-19
,
hepatocellular carcinoma
,
liver neoplasms
,
eosinophilia
,
malignant mesothelioma
,
mesothelioma
,
follicular lymphoma
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
infections
,
respiratory tract infections
,
type 2 diabetes mellitus
,
diabetes mellitus
,
communicable diseases
,
virus diseases
,
human influenza
,
eosinophilic esophagitis
,
gastritis
,
enteritis
,
gastroenteritis
,
coronavirus infections
,
coronavirus
,
hematologic diseases
,
hypereosinophilic syndrome
,
leukocyte disorders
,
exercise-induced asthma
,
neuromyelitis optica
,
breast neoplasms
,
asthma
,
systemic lupus erythematosus
,
pulmonary eosinophilia
,
immunologic deficiency syndromes
,
inflammation
,
diagnosis
PRV-3279
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use